48 related articles for article (PubMed ID: 24226851)
1. In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.
Accardi L; Paolini F; Mandarino A; Percario Z; Di Bonito P; Di Carlo V; Affabris E; Giorgi C; Amici C; Venuti A
Int J Cancer; 2014 Jun; 134(11):2742-7. PubMed ID: 24226851
[TBL] [Abstract][Full Text] [Related]
2. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
[TBL] [Abstract][Full Text] [Related]
3. Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.
Aarthy M; Panwar U; Singh SK
Sci Rep; 2020 May; 10(1):8661. PubMed ID: 32457393
[TBL] [Abstract][Full Text] [Related]
4. Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.
Tuong ZK; Noske K; Kuo P; Bashaw AA; Teoh SM; Frazer IH
Papillomavirus Res; 2018 Jun; 5():6-20. PubMed ID: 29807614
[TBL] [Abstract][Full Text] [Related]
5. LALF
Yanez RJR; Lamprecht R; Granadillo M; Torrens I; Arcalís E; Stöger E; Rybicki EP; Hitzeroth II
Plant Biotechnol J; 2018 Feb; 16(2):628-637. PubMed ID: 28733985
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
Lo Cigno I; Calati F; Girone C; Borgogna C; Venuti A; Boldorini R; Gariglio M
Br J Cancer; 2023 Nov; 129(11):1863-1874. PubMed ID: 37838812
[TBL] [Abstract][Full Text] [Related]
7. Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies.
Donà MG; Di Bonito P; Chiantore MV; Amici C; Accardi L
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502053
[TBL] [Abstract][Full Text] [Related]
8. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers.
Dong Z; Hu R; Du Y; Tan L; Li L; Du J; Bai L; Ma Y; Cui H
Front Immunol; 2020; 11():586796. PubMed ID: 33488587
[TBL] [Abstract][Full Text] [Related]
9. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors.
Paolini F; Amici C; Carosi M; Bonomo C; Di Bonito P; Venuti A; Accardi L
J Exp Clin Cancer Res; 2021 Jan; 40(1):37. PubMed ID: 33485370
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress.
Giacomini A; Taranto S; Rezzola S; Matarazzo S; Grillo E; Bugatti M; Scotuzzi A; Guerra J; Di Trani M; Presta M; Ronca R
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317057
[TBL] [Abstract][Full Text] [Related]
11. Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs.
Amici C; Donà MG; Chirullo B; Di Bonito P; Accardi L
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640530
[TBL] [Abstract][Full Text] [Related]
12. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.
Zhang C; Ötjengerdes RM; Roewe J; Mejias R; Marschall ALJ
BioDrugs; 2020 Aug; 34(4):435-462. PubMed ID: 32301049
[TBL] [Abstract][Full Text] [Related]
13. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
[TBL] [Abstract][Full Text] [Related]
14. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
Ferrantelli F; Arenaccio C; Manfredi F; Olivetta E; Chiozzini C; Leone P; Percario Z; Ascione A; Flego M; Di Bonito P; Accardi L; Federico M
Int J Nanomedicine; 2019; 14():8755-8768. PubMed ID: 31806970
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.
Sadri Nahand J; Moghoofei M; Salmaninejad A; Bahmanpour Z; Karimzadeh M; Nasiri M; Mirzaei HR; Pourhanifeh MH; Bokharaei-Salim F; Mirzaei H; Hamblin MR
Int J Cancer; 2020 Jan; 146(2):305-320. PubMed ID: 31566705
[TBL] [Abstract][Full Text] [Related]
16. Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.
Flego M; Frau A; Accardi L; Mallano A; Ascione A; Gellini M; Fanunza E; Vella S; Di Bonito P; Tramontano E
BMC Biotechnol; 2019 Sep; 19(1):64. PubMed ID: 31488108
[TBL] [Abstract][Full Text] [Related]
17. HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.
Paolini F; Curzio G; Cordeiro MN; Massa S; Mariani L; Pimpinelli F; de Freitas AC; Franconi R; Venuti A
Hum Vaccin Immunother; 2017 Feb; 13(2):291-297. PubMed ID: 27929754
[TBL] [Abstract][Full Text] [Related]
18. Generation of affibody molecules specific for HPV16 E7 recognition.
Xue X; Wang B; Du W; Zhang C; Song Y; Cai Y; Cen D; Wang L; Xiong Y; Jiang P; Zhu S; Zhao KN; Zhang L
Oncotarget; 2016 Nov; 7(45):73995-74005. PubMed ID: 27659535
[TBL] [Abstract][Full Text] [Related]
19. Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm?
Marschall AL; Dübel S
Comput Struct Biotechnol J; 2016; 14():304-8. PubMed ID: 27570612
[TBL] [Abstract][Full Text] [Related]
20. A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.
Amici C; Visintin M; Verachi F; Paolini F; Percario Z; Di Bonito P; Mandarino A; Affabris E; Venuti A; Accardi L
Oncotarget; 2016 Mar; 7(13):15539-53. PubMed ID: 26788990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
